SF0426OA6643/072026
13/07/2028
Active ingredient:
Ondansetron 8 mg.
Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).
Dosage form
Solution for Intramuscular or Intravenous Injection or Intravenous Infusion.
Active ingredient:8 mg dexamethasone phosphate. Therapeutic indications:Indicated for all...
Read More
Active ingredient:Ondansetron 4 mg. Therapeutic indications:Indicated for the management...
Read More
Active ingredient:20 mg Esomeprazole Therapeutic indications: Indicated for gastro-oesophageal Reflux...
Read More
Factory Locations
Quick Links
© 2024 All rights reserved @PHARO PHARMA
Terms and Conditions | Privacy Policy
